Information Technology - News & Updates

Biotechnology company Network Bio has announced a research collaboration with Duke University to develop artificial intelligence (AI) models that could improve disease detection,…
Read More...

Appian and PSI CRO have formed a strategic partnership to use artificial intelligence (AI) and automation to improve clinical trial operations and speed up the drug development process.…
Read More...

Pathos AI has announced strategic collaborations with Bristol Myers Squibb (BMS) and Tempus AI to use artificial intelligence (AI) to advance drug development for Alzheimer’s disease…
Read More...

Big pharma is investing in AI drug discovery through major partnerships with biotech and technology companies, aiming to find new drug targets and develop medicines faster.
Read More...

Zealand Pharma and Generate Biomedicines have announced a strategic collaboration to develop AI-designed protein therapies for obesity and other metabolic diseases. The partnership will…
Read More...

Cognizant has extended its partnership with Gilead Sciences for five years to support the biopharmaceutical company’s technology programs, with a focus on DevOps and the responsible use…
Read More...

AbbVie has entered into a new collaboration with life sciences AI company Valkai to expand the use of artificial intelligence across selected areas of clinical development. The…
Read More...

Genialis and Inventia Life Science have announced a collaboration aimed at improving how new pancreatic cancer treatments are tested and matched to patients who may benefit from them.…
Read More...

Basecamp Research has raised $140 million in a Series C financing round to develop its artificial intelligence platform and advance a pipeline of AI-designed medicines toward clinical…
Read More...

SandboxAQ has announced the general availability of AQPotency, an AI-powered model designed to help drug discovery teams predict how strongly potential drug molecules may act on disease…
Read More...

Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment of a second NVIDIA DGX SuperPOD, strengthening its efforts to…
Read More...

Excalipoint Therapeutics and DP Technology have announced a strategic collaboration to develop a new artificial intelligence (AI) platform designed to speed up the discovery of T-cell…
Read More...

Evogene has partnered with Tel Aviv University’s Blavatnik Center for Drug Discovery to establish a joint initiative aimed at accelerating small-molecule drug discovery programmes…
Read More...

Certara, Inc. has announced a collaboration with NVIDIA aimed at expanding the use of agentic artificial intelligence across drug discovery and development workflows. The partnership…
Read More...

Bayer has entered into a strategic drug discovery collaboration with Iambic Therapeutics to accelerate the development of new small-molecule medicines using artificial intelligence. The…
Read More...

XtalPi has entered into a strategic collaboration with a leading international biopharmaceutical company to develop a next-generation small-molecule therapy targeting a complex G…
Read More...

Alnylam Pharmaceuticals and Inceptive Nucleics have entered into a strategic collaboration valued at up to $2 billion aimed at accelerating the development of next-generation RNA-based…
Read More...

Insilico Medicine and Human Life Foundation Models, Inc. (HLFM) have entered into a multi-million-dollar collaboration to develop what the companies describe as the biotechnology…
Read More...

Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery for biotechnology companies through a success-based artificial…
Read More...

QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...